Skip to content

The comparison of the effectiveness of acupressure and Iboprofen on primary dysmenorrheal

The comparison of the effectiveness of acupressure at the sanyinjiao point (sp6) and Iboprofen on primary dysmenorrhea (spasmodic, congestive)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138901253706N1
Enrollment
72
Registered
2010-09-21
Start date
2010-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea. Primary dysmenorrhoea

Interventions

Intervention 1: Intervention group: An expert in acupressure will instruct method of pressure to the participants and will ask them to use this method during dysmenorrhea. Every paricipant should pres
Treatment - Drugs
Intervention group: An expert in acupressure will instruct method of pressure to the participants and will ask them to use this method during dysmenorrhea. Every paricipant should press sp6 point by h
Control group: Ibuprofen Tabs (400 mg) every 6 hours if needed.

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 22 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Single, age 18-22, Having regular menstrual cycle (mensturation length 3-8 days and length of menstrual cycle 21-35 days) and suffering from dysmenorrhea in previous two years, pain score more than 5 according to visual analogue scale (medium to severe dysmenorrhea), lack of known pelvic disease and known physical and mental diseases, Non consumption of oral contraceptive pills, Lack of pain throughout menstrual cycle or throughout menstrual bleeding, Lack of allergy to NSAIDs, lack of ulcer and inflammatory or skin disease around sp6 point. Exclusion Criteria: Occurrence of Pelvic disease, pelvic and abdomen operations, high emotional stress (parents' divorce, relative death, etc).

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Symptom severity. Timepoint: for three months; first tow days of menstrual cycle in spasmodic dysmenorrhea, two days before menstrual bleeding in congestive dysmenorrhea. Method of measurement: Symptom Severity Scale (SSS).

Secondary

MeasureTime frame
Rest lenght. Timepoint: for three months; first tow days of menstural cycle in spasmodic dysmenorrhea, two days before menstural bleeding in congestivedysmenorrhea. Method of measurement: reported rest lenght (hour) by participant.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Shabani Nashtaei

Tabriz University of Medical Sciences, Aras Unit

mshabaninashtaei@yahoo.com , maryam.shabani.n@gmail.com+98 49 2302 2778

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026